Cargando...
Letter: ACE2, IBD and COVID‐19—why IBD patients may be at reduced risk of COVID‐19
LINKED CONTENT This article is linked to Taxonera et al paper. To view this article, visit https://doi.org/10.1111/apt.15804
Guardado en:
| Publicado en: | Aliment Pharmacol Ther |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7537250/ https://ncbi.nlm.nih.gov/pubmed/33105980 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.16063 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|